Herbas VPB

Print
EN | LT
Supplementary protection
LT - Muskarininio receptoriaus antagonisto ir beta-2 adrenoreceptoriaus agonisto deriniai
EN - Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
SPC
(11) Number of the document C 2506844
(68) Number of the document 2506844
(21) Application number for Supplementary Protection Certificate PA 2018 011
(22) Date of filing the application 2018-06-07
(41) Date of publication of the application 2018-06-25
Date of publication of SPC 2022-10-10
(24) Date of coming into effect of SPC 2030-11-30
Applicant
(71) Glaxo Group Limited, 980 Great West Road, Brentford, Middlesex TW8 9GS, GB
Grantee
(73) Glaxo Group Limited, 980 Great West Road, Brentford, Middlesex TW8 9GS, GB
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
(93) EU/1/17/1236, 2017-11-15
Calculated date of expiry of the SPC
(94) 2032-11-17
Name of the product protected by the basic patent
(95) Umeklidinas arba farmaciniu požiūriu priimtina jo druska (pvz., umeklidino bromidas), vilanterolis arba farmaciniu požiūriu priimtina jo druska (pvz., vilanterolio trifenatatas) ir flutikazono furoatas
Legal status
SPC granted
Last update date 2022-10-07